Onderzoeker
Mathijs Baens
- Trefwoorden:Biomedische wetenschappen
Affiliaties
- Humaan Genoomlaboratorium (Afdeling)
Lid
Vanaf1 mrt 2009 → 31 aug 2017
Projecten
1 - 2 of 2
- Moleculaire en functionele karakterizering van MALT1 en AP12-MALT1-gemedieerde NF-kappaB activiteit in lymfoomontwikkeling.Vanaf1 jan 2012 → 31 dec 2017Financiering: FWO Onderzoeksproject
- Moleculaire en functionele karakterizering van MALT1- en AP12-MALT1-gemedieerde NF-#954;B activiteit in lymfoomontwikkeling.Vanaf1 jan 2008 → 31 dec 2011Financiering: FWO Onderzoeksproject
Publicaties
1 - 10 van 14
- GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein(2020)
Auteurs: Mathijs Baens
Pagina's: 1036 - 1051 - MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner(2019)
Auteurs: Mathijs Baens
- The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling(2014)
Auteurs: Mathijs Baens
Pagina's: 2520 - 30 - MALT1 Auto-Proteolysis Is Essential for NF-κB-Dependent Gene Transcription in Activated Lymphocytes(2014)
Auteurs: Mathijs Baens, Stephen Weeks, Peter Marynen
- Recurrent breakpoints in the 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes(2012)
Auteurs: Mathijs Baens, Lucienne Michaux, Thomas Tousseyn, Julio Antonio Finalet Ferreiro, Peter Van Loo, Daan Dierickx, Christiane Peeters, Peter Vandenberghe
Pagina's: 2449 - 2455 - t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and upregulates GPR34(2012)
Auteurs: Mathijs Baens, Julio Antonio Finalet Ferreiro, Thomas Tousseyn, Lucienne Michaux, Daan Dierickx, Xavier Sagaert, Peter Vandenberghe, Christiane Peeters
Pagina's: 184 - 188 - T(X;14)(p11.4;q32.33) Is Recurrent In Marginal Zone Lymphoma and Upregulates GPR34(2011)
Auteurs: Iwona Wlodarska, Julio Finalet Ferreiro, Thomas Tousseyn, Helena Urbankova, Lucienne Michaux, Laurence de Leval, Daan Dierickx, Pascal Wolter, Xavier Sagaert, Peter Vandenberghe, et al.
Pagina's: 593 - 594 - MALT1 Protease: A New Therapeutic Target in B Lymphoma and Beyond?(2011)
Auteurs: Mathijs Baens
Pagina's: 6623 - 6631 - Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-kappa B Activation(2011)
Auteurs: Xavier Sagaert, Peter Van Loo, Mathijs Baens
Pagina's: 468 - 472 - DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma(2010)
Auteurs: Mathijs Baens
Pagina's: 265 - 274